A 3-year follow-up study of atropine treatment for progressive myopia in Europeans.

Jan Roelof PollingEmily TanSjoerd DriessenSjoukje E LoudonHoi-Lam WongAstrid van der SchansJ Willem L TidemanCaroline C W Klaver

Published in: Eye (London, England) (2020)

In children with or at risk of developing high myopia, a starting dose of atropine 0.5% was associated with decreased progression in European children during a 3-year treatment regimen. Our study supports high-dose atropine as a treatment option for children at risk of developing high myopia in adulthood.

Keyphrases

high dose
young adults
multiple sclerosis
low dose
depressive symptoms
optical coherence tomography